Since the beginning of the epidemic season in Kazakhstan, i.e. since October 1, 2022, 764,247 cases of acute respiratory viral infections (ARVI) have been registered. Roza Kozhapova, head of the Department for Epidemiological Surveillance of Infectious Diseases of the Committee for Sanitary and Epidemiological Control of the Ministry of Health, announced this.
SARS and influenza are the most widespread diseases occurring throughout the year, but most often in autumn and winter. According to WHO, up to 1 billion cases of SARS are registered annually in the world.
Such frequent lesions of the respiratory tract are explained by:
- variety of etiological factors of SARS (more than 200 pathogens of respiratory infections),
- speed and ease of transmission of pathogens (airborne),
- their high contagiousness and variability.
The most common SARS in childhood. Their share, together with influenza, is at least 70% in the structure of all morbidity in children.
The medical and social significance of the problem is determined by the high prevalence of acute respiratory viral infections, high contagiousness, an increase in the allergization of the population, and possible severe complications. The economic damage to the state caused by one case of SARS is $100-170, the damage for each case of SARS is $50-100 (Baranov A. A. et al.).
Given this, it is quite natural that special attention in our country is paid to the treatment and prevention of acute respiratory infections in children and adults.
In connection with the relevance of this topic and in order to increase the awareness of medical workers on this topic, Ph.D., acting. Guliya Tuleutaevna Kamasheva, of the Department of General Medicine in Semey, SMU, NCJSC, 29.11.2022 у. gave a lecture on the topic “Treatment and prevention of acute respiratory viral infections and influenza in children and adults” to the staff of the KSE on the REM “Polyclinic No. 4 of Semey” of the OA. The lecture was interesting, all questions of the audience were answered.